Dr Faith Howard

PhD, BSc (Hons).

School of Medicine and Population Health

Bicentennial Research Fellow

Dr Faith Howard
Dr Faith Howard
Profile picture of Dr Faith Howard
f.howard@sheffield.ac.uk
+44 114 215 9200
EU27, E Floor, The Medical School

Full contact details

Dr Faith Howard
School of Medicine and Population Health
EU27, E Floor
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

I joined the University of Sheffield in 2006 as a research technician where I completed a PhD in the Academic Unit of Nephrology in 2013 involving CDK/MEK inhibitors to inhibit fibrosis. In 2011 I joined the department of Clinical Oncology working on breast cancer and metastasis. I have multi-disciplinary, cross-sector experience having worked in industry between the years 2014-2018 in the AMR field before returning to the University of Sheffield and the study of breast cancer. My current research involves . 

Nanobug Oncology Sheffield
Nanobug Oncology Sheffield
Research interests

My research interests are focused on delivery of therapeutics to disseminated tumours. This includes nanoenabled formulations and the development of appropriate models for studying immunotherapies.

Publications

Show: Featured publications All publications

Journal articles

  • Howard F, Conner J, Danson S & Muthana M (2022) . Frontiers in Molecular Biosciences, 9.
  • Howard FHN, Al‐Janabi H, Patel P, Cox K, Smith E, Vadakekolathu J, Pockley AG, Conner J, Nohl JF, Allwood DA , Collado‐Rojas C et al (2022) . Small, 18(13).
  • Howard F & Muthana M (2020) . Nanomedicine, 15(1), 93-110.
  • Lefley D, Howard F, Arshad F, Bradbury S, Brown H, Tulotta C, Eyre R, Alférez D, Wilkinson JM, Holen I , Clarke RB et al (2019) . Breast Cancer Research, 21(1).
  • Iscaro A, Howard NF & Muthana M (2019) . Current Pharmaceutical Design, 25(17), 1962-1979.
  • Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR, Nutter-Howard F, Wilkinson JM, Spicer-Hadlington AR, Liu X , Bradbury S et al (2019) . Clinical Cancer Research, 25(9), 2769-2782.
  • Holen I, Walker M, Nutter F, Fowles A, Evans CA, Eaton CL & Ottewell PD (2016) . Clinical & Experimental Metastasis, 33(3), 211-224.
  • Nutter FH, Haylor JL & Khwaja A (2015) . PLOS ONE, 10(9).
  • Holen I, Nutter F, Wilkinson JM, Evans CA, Avgoustou P & Ottewell PD (2015) . Clinical & Experimental Metastasis, 32(7), 689-702.
  • Nutter F, Holen I, Brown HK, Cross SS, Evans CA, Walker M, Coleman RE, Westbrook JA, Selby PJ, Brown JE & Ottewell PD (2014) . Endocrine-Related Cancer, 21(2), 327-341.
  • Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, Vasiliadou I, Ottewell PD & Holen I (2013) . Cellular Oncology, 36(6), 505-514.
  • Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M & Ottewell PD (2012) . Breast Cancer Research, 14.
  • Nutter F, Khwaja A & Haylor J () . Nephron Experimental Nephrology, 122(3-4), 114-122.

Book chapters

  • Nutter Howard FH, Iscaro A & Muthana M (2022) , Systemic Drug Delivery Strategies (pp. 211-230). Elsevier

All publications

Journal articles

  • Mansor MH, Williamson L, Ludwikowski D, Howard F & Muthana M (2025) . Physchem, 5(3).
  • Gao Z, Mansor MH, Howard F, MacInnes J, Zhao X & Muthana M (2025) . Nanomaterials, 15(3).
  • Mansor MH, Gao Z, Howard F, MacInnes J, Zhao X & Muthana M (2025) . Pharmaceutics, 17(1).
  • Beetham B, Fasola C & Howard F (2025) . OMEGA - Journal of Death and Dying, 90(3), 1043-1055.
  • von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM , Kerbrat P et al (2023) . Journal of Clinical Oncology, 41(23), 3881-3890.
  • Patel P, Alghamdi A, Shaw G, Legge C, Glover M, Freeman D, Hodgetts H, Wilson E, Howard F, Staniland S , Kennerley AJ et al (2023) . Nanotheranostics, 7(1), 102-116.
  • Kwan A, Howard F, Winder N, Atkinson E, Jailani A, Patel PB, Allen R, Ottewell PD, Shaw GC, Conner J , Wilson C et al (2022) . Future Pharmacology, 2(4), 444-459.
  • Howard FHN, Kwan A, Winder N, Mughal A, Collado-Rojas C & Muthana M (2022) . Viruses, 14(7).
  • Howard F, Conner J, Danson S & Muthana M (2022) . Frontiers in Molecular Biosciences, 9.
  • Howard FHN, Al‐Janabi H, Patel P, Cox K, Smith E, Vadakekolathu J, Pockley AG, Conner J, Nohl JF, Allwood DA , Collado‐Rojas C et al (2022) . Small, 18(13).
  • Iscaro A, Jones C, Forbes N, Mughal A, Howard FN, Janabi HA, Demiral S, Perrie Y, Essand M, Weglarz A , Cruz LJ et al (2022) . Nanomedicine: Nanotechnology, Biology and Medicine, 40.
  • Howard F & Muthana M (2020) . Nanomedicine, 15(1), 93-110.
  • Lefley D, Howard F, Arshad F, Bradbury S, Brown H, Tulotta C, Eyre R, Alférez D, Wilkinson JM, Holen I , Clarke RB et al (2019) . Breast Cancer Research, 21(1).
  • Iscaro A, Howard NF & Muthana M (2019) . Current Pharmaceutical Design, 25(17), 1962-1979.
  • Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR, Nutter-Howard F, Wilkinson JM, Spicer-Hadlington AR, Liu X , Bradbury S et al (2019) . Clinical Cancer Research, 25(9), 2769-2782.
  • Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M & Ottewell PD (2017) . Breast Cancer Research, 19.
  • Burhan I, Furini G, Lortat-Jacob H, Atobatele AG, Scarpellini A, Schroeder N, Atkinson J, Maamra M, Nutter FH, Watson P , Vinciguerra M et al (2016) . Scientific Reports, 6.
  • Holen I, Walker M, Nutter F, Fowles A, Evans CA, Eaton CL & Ottewell PD (2016) . Clinical & Experimental Metastasis, 33(3), 211-224.
  • Nutter FH, Haylor JL & Khwaja A (2015) . PLOS ONE, 10(9).
  • Holen I, Nutter F, Wilkinson JM, Evans CA, Avgoustou P & Ottewell PD (2015) . Clinical & Experimental Metastasis, 32(7), 689-702.
  • Nutter F, Holen I, Brown HK, Cross SS, Evans CA, Walker M, Coleman RE, Westbrook JA, Selby PJ, Brown JE & Ottewell PD (2014) . Endocrine-Related Cancer, 21(2), 327-341.
  • Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, Vasiliadou I, Ottewell PD & Holen I (2013) . Cellular Oncology, 36(6), 505-514.
  • Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M & Ottewell PD (2012) . Breast Cancer Research, 14.
  • Haylor J, Schroeder J, Wagner B, Nutter F, Jestin G, Idée J-M & Morcos S (2012) . Radiology, 263(1), 107-116.
  • Ottewell PD, Whitworth J, Cross SS, Nutter FH & Holen I (2011) . Cancer Research, 71(24_Supplement).
  • Haylor J, Dencausse A, Vickers M, Nutter F, Jestin G, Slater D, Idee J-M & Morcos S (2010) . Investigative Radiology, 45(9), 507-512.
  • Wilson C, Nutter F, Brown H, Coleman R & Holen I () . Bone Abstracts.
  • Nutter F, Khwaja A & Haylor J () . Nephron Experimental Nephrology, 122(3-4), 114-122.

Book chapters

  • Nutter Howard FH, Iscaro A & Muthana M (2022) , Systemic Drug Delivery Strategies (pp. 211-230). Elsevier
  • H.N. Howard F, Gao Z, Bin Mansor H, Yang Z & Muthana M () , Biomedical Engineering IntechOpen
  • Iscaro A, H.N. Howard F, Yang Z, Jenkins F & Muthana M () , Liposomes - Recent Advances, New Perspectives and Applications IntechOpen

Conference proceedings

  • AL-Janabi H, Conner J, Howard F, Hunt S, Taher Z, Staniland S & Muthana M (2019) . Cancer Research, Vol. 79(13_Supplement)
  • AL-Janabi H, Conner J, Howard F, Hunt S, Taher Z, Staniland S & Muthana M (2019) . Immunology
Research group

Member of Nanobug Oncology Sheffield () team led by Dr Munitta Muthana.

Grants

2022 British Association of Cancer, Roger Griffin Prize for Cancer Discovery.

2022 Early Career Researcher Prize for Outstanding Contribution to Research, Engagement and Leadership by Faculty of Medicine, Dentistry & Health, University of Sheffield.

2019 EPSRC NanoPrime Grant (EP/K005138/1A).

2018 CRUK New Investigator Committee - Research Travel Award.

Teaching interests

I teach Immunology on the MBChB course and am module lead for Home Office Personal Licence holders. I also supervise research projects for the medical school MSc. Molecular Medicine and MSc. Translational Oncology courses. 

Professional activities and memberships
  • Steering Committee member of the ECMC Junior Investigator Networking Group.
  • Member of NCRI ECR Forum.
  • Member of UKRI ECR Forum.
  • Reviewer for ACS Nano, ACS Applied Materials and Interfaces, Advanced Therapeutics.